The aim of this assay is to characterize selectivity of compounds originally identified in "Image-based HTS for Selective Antagonists of GPR35" (AID 2058) against the unrelated vasopressin receptor. Compounds were either acquired from commercial sources or synthesized by the Sanford-Burnham Center for Chemical Genomics. This imaging assay utilizes a cell line permanently expressing a beta-arrestin GFP biosensor and human vasopressin receptor type IIa.  Upon agonist-mediated GPCR activation, the arrestin-GFP redistributes from the cytosolic compartment to the plasma membrane to coated pits. This arrestin-GFP redistribution is measured as increased local concentrations of fluorescent arrestins. Assay Materials: 1) 384-well plates, black with clear bottom (MatriCal# MGB101-1-2) 2) U2OS (Human Osteosarcoma) cell line stably expressing the Beta-arrestin 2 GFP and human vasopressin IIa receptor 3) Culture Media: MEM with L-glutamine, Pen-strep, 10% Fetal Bovine Serum and selection antibiotics - 200 ug/ml G418 and 100 ug/ml Zeocin 4) Positive Control: Arginine Vasopressin 5) DMSO solution 6) Test Compounds in 100% DMSO 7) Fixative Working Solution: 2% Paraformaldehyde (PFA) diluted in PBS Assay Procedure: 1) Cells were seeded at 12,000 cells/well in a 384 well plate (black with clear bottom)  2) Plates are incubated overnight at 37 degree C and 5% CO2 3)   Serum was removed by media aspiration and replaced with serum-free media. 4) Agonist control (Arginine Vasopressin) was added to columns 2 at 0, 0.01 uIU/ml, 0.1 uIU/ml, 1 uIU/ml, 10 uIU/ml, 100 uIU/ml, 1 mIU/ml, and 10 mIU/ml (EC80 concentration=16 nM, equivalent to 10 uIU/ml) 5) Compounds were added to columns 3 to 22 at 10 uM final concentration and 0.1% DMSO 6) DMSO was added to column 23 for a final concentration of 0.1% 7) Plates were incubated for 40 minutes at 37 degrees C and 5% CO2  8) Fixative solution was added to each well for a final concentration of 1% PFA 9) Plates were incubated overnight at 4 degree C Image Acquisition and Analysis: 1)   Image acquisition was performed on a Zeiss Axiovert 200M fluorescent microscope using the following settings:   Plan-APOCHRMAT 40x /0.95 korr air objective Acquisition camera providing an image with 1388 by 1040 pixels   1 channel: Beta-arrestin GFP using 488 nm laser excitation and 540/70 nm emission filters   2 fields per well 2) Image analysis was performed using a Wavelet Algorithm using the Batchmode computer software. The number of detected GFP-beta-arrestin aggregates ("# of Spots") was used as the assay read-out. 4) %Activity of the test compounds was calculated based on the number of detected aggregates ("# of Spots") as compared to the negative (0.01 uIU/ml) and positive (10mIU/ml) controls. Compounds with %Activity > 50% for both datasets at 10 uM were considered active.
bao:BAO_0000541 "2058" ; # "is counter assay of" -> "2058"
bao:BAO_0000812 "2079" ; # "has summary assay" -> "2079"
bao:BAO_0000210 bao:BAO_0000032 ; # "has assay stage" -> "secondary assay"
bao:BAO_0001070 bao:BAO_0001064 ; # "has alternate target assay" -> "alternate target assay"
bao:BAO_0000205 bao:BAO_0000219 ; # "has assay format" -> "cell-based format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000284 ; # "has participant" -> "G protein coupled receptor" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 bao:BAO_0000378 ; # "is bioassay type of" -> "protein redistribution assay"
bao:BAO_0000212 bao:BAO_0000126 ; # "has assay method" -> "molecular redistribution determination method"
bao:BAO_0000207 bao:BAO_0000363 ; # "has detection method" -> "fluorescence intensity"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "\"Compounds binding the GPR35, antagonists\"" ; # "screening campaign name" -> ""Compounds binding the GPR35, antagonists""
bao:BAO_0002853 "SAR Analysis using an Image-based Vasopressin Agonist Counter Assay for the Identification of Selective Antagonists of the GPR35 Receptor" ; # "has assay title" -> "SAR Analysis using an Image-based Vasopressin Agonist Counter Assay for the Identification of Selective Antagonists of the GPR35 Receptor"
bao:BAO_0002854 bao:BAO_0000010 ; # "has bioassay type" -> "functional"
bao:BAO_0002867 bao:BAO_0000515 ; # "has assay footprint" -> "384 well plate"
bao:BAO_0000109 "37 degree celsius" ; # "has temperature value" -> "37 degree celsius"
bao:BAO_0002833 "40 minute" ; # "has incubation time value" -> "40 minute"
bao:BA0_0090012 bao:BAO_0001044 ; # "has participant" -> "Vasopressin"
bao:BAO_0000740 bao:BAO_0000080 ; # "has assay control" -> "positive control"
bao:BA0_0090012 bao:BAO_0000118 ; # "has participant" -> "DMSO"
bao:BAO_0000740 bao:BAO_0000079 ; # "has assay control" -> "negative control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Lawrence Barak" ; # "material entity assay provider" -> "Lawrence Barak" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000373 ; # "has assay phase characteristic" -> "heterogeneous phase"
bao:BAO_0000118 "0.10%" ; # "DMSO" -> "0.10%"
bao:BA0_0090012 "Vasopressin V2 receptor" ; # "has participant" -> "Vasopressin V2 receptor"
bao:BAO_0002004 <http://purl.obolibrary.org/obo/CLO_0009454> ; # "has cell line" -> "U-2 OS cell"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "554" ; # "gene ID" -> "554"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "P30518" ; # "uniprot ID" -> "P30518"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10% fetal bovine serum" ; # "material entity culture serum" -> "10% fetal bovine serum" || bao:BAO_0003102 bao:BAO_0002596 ; # "has role" -> "culture serum"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "\"MEM with L-glutamine, Pen-strep, 10% FBS, 200 microg/ml G418 and 100 microg/ml Zeocin\"" ; # "material entity culture medium" -> ""MEM with L-glutamine, Pen-strep, 10% FBS, 200 microg/ml G418 and 100 microg/ml Zeocin"" || bao:BAO_0003102 bao:BAO_0000114 ; # "has role" -> "culture medium"
bao:BAO_0002922 "serum-free MEM" ; # "has assay medium" -> "serum-free MEM"
bao:BAO_0002922 bao:BAO_0000596 ; # "has assay medium" -> "assay medium"
bao:BAO_0000212 bao:BAO_0000246 ; # "has assay method" -> "stable transfection"
bao:BAO_0000550 "Expressing a beta-arrestin 2 GFP biosensor and the human vasopressin V2 receptor" ; # "DNA construct" -> "Expressing a beta-arrestin 2 GFP biosensor and the human vasopressin V2 receptor"
bao:BAO_0003105 "arginine vasopressin receptor 2" ; # "has function" -> "arginine vasopressin receptor 2"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "554" ; # "construct gene ID" -> "554"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0003105 "beta-arrestin GFP" ; # "has function" -> "beta-arrestin GFP" || bao:BAO_0003102 bao:BAO_0002656 ; # "has role" -> "reporter gene"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BA0_0090012 bao:BAO_0000854 ; # "has participant" -> "Arrestin-GFP"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0002153 ; # "has signal direction" -> "signal increase corresponding to inhibition"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0002865 bao:BAO_0000857 ; # "uses detection instrument" -> "AxioVert 200M Fluorescence Light Microscope"
bao:BAO_0000737 bao:BAO_0001055 ; # "has manufacturer" -> "Zeiss" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "488 nanometer" ; # "has excitation wavelength value" -> "488 nanometer"
bao:BAO_0002918 "540 nanometer" ; # "has emission wavelength value" -> "540 nanometer"
bao:BAO_0000337 bao:BAO_0000200 ; # "has percent response" -> "percent activation"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "1" ; # "PubChem TID" -> "1"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002666 "10" ; # "has concentration value" -> "10"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
bao:BAO_0002787 "1" ; # "has concentration-point number" -> "1"
bao:BAO_0000196 bao:BAO_0000087 ; # "has mode of action" -> "activation"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "mp" ; # "Annotated by" -> "mp"
